Valeant shares down again: 5 key notes on the stock

Laval, Canada-based Valeant Pharmaceuticals stocks were down 4 percent from Dec. 22, 2016 to Dec. 29, 2016.

Advertisement

Here’s what you should know.

1. The stock’s five day high was $14.71 on Dec. 22, 2016.

2. Valeant’s stock hit a five day low of $13.82 on Dec. 28, 2016.

3. Its 52-week range was $13 to $105.93 per share.

4. The company has a market cap of $4.87 billion and a negative earnings per share of $6.48.

5. As of 11:30 a.m. Dec. 30, 2016, Valeant was trading at $14.58.

More articles on GI/endoscopy:
GI leader to know: Dr. Glenn Littenberg of Gastroenterology Associates
Future of esophageal screening may rest in patient’s nose: 5 key notes
GI leader to know: Dr. Nicholas Weber of CHI Franciscan Health

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.